| A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation (NCT07752875) | LG Chem | 2026-12-01 |
| A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty (NCT07710430) | LG Chem | 2026-08-01 |
| The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers (NCT07396844) | LG Chem | 2026-07-01 |
| A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting. (NCT07399470) | LG Chem | 2026-01-09 |
| A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal (NCT07333742) | LG Chem | 2025-09-29 |
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series (NCT06947499) | LG Chem | 2025-05-30 |
| Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET). (NCT06921395) | LG Chem | 2025-02-15 |
| A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability (NCT06743997) | LG Chem | 2025-01-13 |
| Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age (NCT06618196) | LG Chem | 2024-10-02 |
| Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC (NCT06332755) | LG Chem | 2024-06-05 |
| A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity (NCT06041841) | LG Chem | 2023-12-01 |
| Effect of Tigulixostat on the Pharmacokinetics of Theophylline (NCT06189404) | LG Chem | 2023-10-31 |
| Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients (NCT06495281) | LG Chem | 2023-10-26 |
| A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults (NCT05952596) | LG Chem | 2023-07-17 |
| Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series (NCT05457946) | LG Chem | 2023-04-01 |
| Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients (NCT05586971) | LG Chem | 2023-03-30 |
| Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants (NCT05431933) | LG Chem | 2023-01-10 |
| Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients (NCT05586958) | LG Chem | 2022-10-25 |
| A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA (NCT05237752) | LG Chem | 2022-04-27 |
| A Study of LC542019 in Healthy Subjects and Subjects With T2DM (NCT06333977) | LG Chem | 2022-03-25 |
| Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in China (NCT05314504) | LG Chem | 2022-01-11 |
| Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg (NCT05105698) | LG Chem | 2022-01-01 |
| A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds (NCT05106751) | LG Chem | 2021-10-21 |
| Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects (NCT04966325) | LG Chem | 2021-09-23 |
| Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer (NCT05130125) | LG Chem | 2021-09-14 |
| Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults (NCT04886050) | LG Chem | 2021-07-31 |
| Effectiveness and Safety of YVOIRE Y-Solution 540 (NCT04855188) | LG Chem | 2021-07-01 |
| Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring (NCT04886544) | LG Chem | 2021-06-25 |
| Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus (NCT05281029) | LG Chem | 2021-06-24 |
| To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume (NCT04784299) | LG Chem | 2021-03-22 |
| A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of TT-01025-CL in Healthy Subjects (NCT04730050) | LG Chem | 2021-02-17 |
| To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in Europe (NCT04732793) | LG Chem | 2021-02-03 |
| To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face (NCT04437745) | LG Chem | 2020-11-25 |
| Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg (NCT04544319) | LG Chem | 2020-10-01 |
| To Evaluate Safety and Effectiveness of RovatitanTab. (NCT04398771) | LG Chem | 2020-09-01 |
| Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg. (NCT04317703) | LG Chem | 2020-08-19 |
| Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects (NCT04360343) | LG Chem | 2020-07-01 |
| A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone (NCT04255238) | LG Chem | 2020-06-30 |
| A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer. (NCT04738019) | LG Chem | 2020-06-18 |
| To Evaluate the Performance and Safety of YVOIRE Y Solution 360 Versus Comparator for Lips and Perioral Area. (NCT04299295) | LG Chem | 2020-06-05 |
| Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis (NCT04096573) | LG Chem | 2020-04-01 |
| A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects (NCT06040372) | LG Chem | 2020-03-16 |
| The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults (NCT04139824) | LG Chem | 2020-01-22 |
| A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia (NCT03934099) | LG Chem | 2019-12-02 |
| Renal PK Study of LC350189 (NCT04066712) | LG Chem | 2019-11-19 |
| The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults. (NCT03927677) | LG Chem | 2019-11-05 |
| Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants (NCT04073459) | LG Chem | 2019-11-01 |
| Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg. (NCT04050098) | LG Chem | 2019-11-01 |
| Food-effect Bioavailability of Fixed Dose Combination Zemimet® SR Tab. 50/1000 mg Under Fed and Fasting Conditions (NCT04070794) | LG Chem | 2019-11-01 |
| A Study of YVOIRE Y-Solution 360 for Hand Augmentation to Correct Volume Loss (NCT04112017) | LG Chem | 2019-09-27 |
| A Phase IV Study to Assess the Safety of EupentaTM Inj (NCT04056728) | LG Chem | 2019-09-23 |
| 6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers (NCT04085224) | LG Chem | 2019-09-10 |
| An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I) (NCT03864432) | LG Chem | 2019-07-02 |
| A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study) (NCT03842267) | LG Chem | 2019-05-13 |
| BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination. (NCT03867942) | LG Chem | 2019-03-21 |
| Observational Study to Develop Dosing Chart (NCT04227171) | LG Chem | 2018-08-03 |
| A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults (NCT03549208) | LG Chem | 2018-07-01 |
| Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802 (NCT03532854) | LG Chem | 2018-05-28 |
| A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants (NCT03467984) | LG Chem | 2018-05-25 |
| Gemigliptin, Dapagliflozin, Empagliflozin DDI Study (NCT03565458) | LG Chem | 2018-04-05 |
| Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee (NCT04369261) | LG Chem | 2018-03-09 |
| BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone (NCT03355014) | LG Chem | 2017-12-13 |